Description

Aromasin Description

Aromasin, commonly known as Exemestane (or Aromasin) is a mild and commonly used Aromatase Inhibitor (AI). It becomes invaluable while running steroid cycles with aromatizing anabolic compounds. SERMs bind to estrogen receptors, effectively blocking estrogen from binding to them. Aromatase Inhibitors (AIs) function by blocking the initial formation of the aromatase enzyme, which is a byproduct of administering most anabolic-androgenic steroid (AAS) compounds. Aromagen will significantly lower the body’s serum estradiol levels to a desirable level by inhibiting the aromatase process, mitigating the potential negative side effects. Most steroid cycles will require an AI to prevent elevated estrogen levels and the related side effects.

Effects of Aromasin:

In a therapeutic setting, by blocking the aromatase enzyme, Aromasin actively prohibits the cancer from feeding off the hormone necessary to its survival. It has been proven highly effective for this purpose, but only after the use of the Selective Estrogen Receptor Modulator (SERM) Nolvadex (Tamoxifen Citrate) has failed. While effective, it is also not as commonly used as Arimidex for this purpose as Arimidex largely maintains itself as the primary AI in breast cancer treatment not only among post-menopausal women but in a host of breast cancer scenarios.

Benefits:

• Inhibits the conversion of testosterone into estrogen
• Reduction of estrogenic side effects
• Raises natural testosterone secretion levels
• Reduces blood pressure
• Medication for treatment/prevention of breast cancer
• Can be used as part of a Post Cycle Therapy (PCT) protocol

Terminal Half-life:

• 24 hrs

Possible Dosage & Cycle Length:

• Men @ 12.5-25 mg/every other day, as needed to mitigate side effects
• Use for duration of cycle, only if it is needed